Purpose
Relative supersaturations of calcium oxalate, calcium phosphate, and uric acid are used clinically in kidney stone prevention. The magnitudes of association between relative supersaturation and stone risk require further quantification.
Materials and Methods
We performed a cross-sectional study using 24-hour urine collections from Nurses’ Health Study I (NHS I), Nurses’ Health Study II (NHS II), and Health Professional Follow-up Study (HPFS) cohorts to quantify the association between calcium oxalate, calcium phosphate, and uric acid relative supersaturations levels and likelihood of stone formation.
Results: Odds ratio
(OR) for being a stone former were 5.85 (3.40 to 10.04) in NHS I, 6.38 (3.72 to 11.0) in NHS II, and 6.95 (3.56 to 13.6) in HPFS for the highest category of calcium oxalate relative supersaturation compared with <1.0. The OR for being a stone former were 1.86 (0.94 to 3.71) in NHS I, 4.37 (2.68 to 7.10) in NHS II, and 3.59 (2.04 to 6.31) in HPFS for the highest category of calcium phosphate relative supersaturation compared with <1.0. For uric acid relative supersaturation, OR for being a stone former were 4.30 (2.34 to 7.90) in NHS I and 2.74 (1.71 to 4.40) in NHS II for the highest relative supersaturation category compared with <1.0. In HPFS, uric acid relative supersaturation was not significantly associated with likelihood of stone formation.
Conclusion
Likelihood of being a stone former increases with higher calcium oxalate and calcium phosphate relative supersaturation levels in men and women, and higher relative supersaturation levels of uric acid in women.